Epidemiology and predictive factors for early and late mortality in Candida bloodstream infections: A population-based surveillance in Spain

Clinical Microbiology and Infection

Volumn 20, Issue 4, 2014, Pages

  Puig Asensio, M ^a   Padilla, B ^b,c   Garnacho Montero, J ^d   Zaragoza, O ^e   Aguado, J M ^f   Zaragoza, R ^g   Montejo, M ^h   Munoz P ^b,c   Ruiz Camps, I ^a   Cuenca Estrella, M ^e   Almirante, B ^a   Guinea, Jesús ^b   Pãno, José Ramón ⁱ   García, Julio ⁱ   García, Carlos ⁱ   Fortún, Jesús ^j   Martín, Pilar ^j   Gómez, Elia ^j   Ryan, Pablo ^k   Campelo, Carolina ^k   de los Santos, Ignacio ^l   Buendía, Buenaventura ^l   Perez, Beatriz ^m   Alonso, Mercedes ^m   Sanz, Francisca ^f   Merino, Paloma ⁿ   González, Fernando ⁿ   Gorgolas, Miguel ^o   Gadea, Ignacio ^o   Losa, Juan Emilio ^p   Delgado Iribarren, Alberto ^p   Ramos, Antonio ^q   Romero, Yolanda ^q   Sánchez, Isabel ^q   Rodriguez Bãno, Jeśus ^r   Suarez, Ana Isabel ^r   Loza, Ana ^s   Martín Mazuelos, Estrella ^s   Aller, Ana Isabel ^s   Ruiz, Maite ^d   Ortiz, Carlos ^t   Chávez, Mónica ^u   Maroto, Fernando L ^u   Salavert, Miguel ^v   Pemán, Javier ^v   Blanquer, José ^w   Navarro, David ^w   Abril, Vicente ^x   Gimeno, Concepción ^x   Camarena, Juan José ^g   Hernáez, Silvia ^y   Ezpeleta, Guillermo ^y   Bereciartua, Elena ^h   Hernández, José L ^h   Rivas, Rosa Ana ^z   Ayarza, Rafael ^z   Planes, Ana Ma ^a   Mensa, José ^aa   Almela, Manel ^aa   Gurgui, Mercé ^ab   Sánchez Reus, Ferran ^ab   Martinez Montauti, Joaquin ^ac   Sierra, Montserrat ^ac   Horcajada, Juan Pablo ^ad   Sorli, Luisa ^ad   Gómez, Juliá ^ad   Gené, Amadeu ^ae   Urrea, Mireia ^ae   Valerio, Maricela ^af   Fernández Ruiz, Mario ^af   Díaz Martín, Ana ^af   Puchades, Francesc ^af   Mularoni, Alessandra ^af   more..

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^b HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^c UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^d HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^e INSTITUTO DE SALUD CARLOS III   (Spain)

^f HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^g HOSPITAL UNIVERSITARIO DR PESET   (Spain)

^h HOSPITAL DE CRUCES   (Spain)

ⁱ HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^j HOSPITAL RAMÓN Y CAJAL   (Spain)

^k HOSPITAL UNIVERSITARIO INFANTA LEONOR   (Spain)

^l HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

^m HOSPITAL INFANTIL UNIVERSITARIO NIÑO JESÚS   (Spain)

ⁿ HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^o Grupo de Trabajo Ecografía SoMaMFyC   (Spain)

^p HOSPITAL UNIVERSITARIO FUNDACIÓN ALCORCÓN   (Spain)

^q Upper Limb Unit   (Spain)

^r HOSPITAL UNIVERSITARIO VIRGEN MACARENA   (Spain)

^s HOSPITAL UNIVERSITARIO DE VALME   (Spain)

^t HOSPITAL UNIVERSITARI SAGRAT COR   (Spain)

^u HOSPITAL SAN JUAN DE DIOS DEL ALJARAFE   (Spain)

^v HOSPITAL UNIVERSITARIO LA FE   (Spain)

^w HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^x HOSPITAL GENERAL UNIVERSITARIO DE VALENCIA   (Spain)

^y HOSPITAL DE BASURTO   (Spain)

^z HOSPITAL DE GALDAKAO   (Spain)

^aa INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

^ab HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^ac Hospital de Niños de Barcelona   (Spain)

^ad HOSPITAL DEL MAR   (Spain)

^ae HOSPITAL SANT JOAN DE DÉU   (Spain)

^af Hospital Universitari Vall d'Hebron ^*

more..

Author keywords

Antifungal resistance; Candida bloodstream infections; Early mortality; Epidemiology; Prognostic factors; Surveillance

Indexed keywords

AMPHOTERICIN; ANIDULAFUNGIN; CASPOFUNGIN; FLUCONAZOLE; FLUCYTOSINE; ITRACONAZOLE; MICAFUNGIN; POSACONAZOLE; VORICONAZOLE;

ADULT; AGED; ANTIFUNGAL RESISTANCE; ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; BLOODSTREAM INFECTION; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA KRUSEI; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS; CANDIDIASIS; CATHETER REMOVAL; CENTRAL VENOUS CATHETER; CLAVISPORA LUSITANIAE; COMORBIDITY; DISEASE SEVERITY; DISEASE SURVEILLANCE; DNA SEQUENCE; FEMALE; FUNGUS ISOLATION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; PICHIA GUILLIERMONDII; PREDICTIVE VALUE; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; RISK FACTOR; SEPSIS; SEPTIC SHOCK; SPAIN; SPECIES IDENTIFICATION; VERY ELDERLY;

CANDIDA; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS;

ANTIFUNGAL RESISTANCE; CANDIDA BLOODSTREAM INFECTIONS; EARLY MORTALITY; EPIDEMIOLOGY; PROGNOSTIC FACTORS; SURVEILLANCE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CANDIDA; CANDIDEMIA; CHILD; CHILD, PRESCHOOL; DRUG RESISTANCE, FUNGAL; EPIDEMIOLOGICAL MONITORING; FEMALE; HUMANS; INCIDENCE; INFANT; MALE; MIDDLE AGED; PREVALENCE; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS; SPAIN; SURVIVAL ANALYSIS; URBAN POPULATION; YOUNG ADULT;

EID: 84895926933     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/1469-0691.12380     Document Type: Article

References (36)

1. Marchetti O, Bille J, Fluckiger U et al. Epidemiology of candidemia in Swiss tertiary care hospitals: secular trends, 1991-2000. Clin Infect Dis 2004; 38: 311-320.
2. Poikonen E, Lyytikainen O, Anttila VJ et al. Secular trend in candidemia and the use of fluconazole in Finland, 2004-2007. BMC Infect Dis 2010; 10: 312.
3. Sandven P, Bevanger L, Digranes A, Haukland HH, Mannsaker T, Gaustad P. Candidemia in Norway (1991 to 2003): results from a nationwide study. J Clin Microbiol 2006; 44: 1977-1981.
4. Arendrup MC, Bruun B, Christensen JJ et al. National surveillance of fungemia in Denmark (2004 to 2009). J Clin Microbiol 2011; 49: 325-334.
5. Asmundsdottir LR, Erlendsdottir H, Gottfredsson M. Nationwide study of candidemia, antifungal use, and antifungal drug resistance in Iceland, 2000 to 2011. J Clin Microbiol 2013; 51: 841-848.
6. Almirante B, Rodriguez D, Park BJ et al. Epidemiology and predictors of mortality in cases of Candida bloodstream infection: results from population-based surveillance, Barcelona, Spain, from 2002 to 2003. J Clin Microbiol 2005; 43: 1829-1835.
7. Zaoutis TE, Argon J, Chu J, Berlin JA, Walsh TJ, Feudtner C. The epidemiology and attributable outcomes of candidemia in adults and children hospitalized in the United States: a propensity analysis. Clin Infect Dis 2005; 41: 1232-1239.
8. Lortholary O, Desnos-Ollivier M, Sitbon K, Fontanet A, Bretagne S, Dromer F. Recent exposure to caspofungin or fluconazole influences the epidemiology of candidemia: a prospective multicenter study involving 2, 441 patients. Antimicrob Agents Chemother 2011; 55: 532-538.
9. Kao AS, Brandt ME, Pruitt WR et al. The epidemiology of candidemia in two United States cities: results of a population-based active surveillance. Clin Infect Dis 1999; 29: 1164-1170.
10. Diekema DJ, Messer SA, Brueggemann AB et al. Epidemiology of candidemia: 3-year results from the emerging infections and the epidemiology of Iowa organisms study. J Clin Microbiol 2002; 40: 1298-1302.
11. Hajjeh RA, Sofair AN, Harrison LH et al. Incidence of bloodstream infections due to Candida species and in vitro susceptibilities of isolates collected from 1998 to 2000 in a population-based active surveillance program. J Clin Microbiol 2004; 42: 1519-1527.
12. Cleveland AA, Farley MM, Harrison LH et al. Changes in incidence and antifungal drug resistance in candidemia: results from population-based laboratory surveillance in Atlanta and Baltimore, 2008-2011. Clin Infect Dis 2012; 55: 1352-1361.
13. Rodriguez-Hernandez MJ, Ruiz-Perez de Pipaon M, Marquez-Solero M et al. Candidemias: multicentre analysis in 16 hospitals in Andalusia (Spain). Enferm Infecc Microbiol Clin 2011; 29: 328-333.
14. Peman J, Canton E, Quindos G et al. Epidemiology, species distribution and in vitro antifungal susceptibility of fungaemia in a Spanish multicentre prospective survey. J Antimicrob Chemother 2012; 67: 1181-1187.
15. Kollef M, Micek S, Hampton N, Doherty JA, Kumar A. Septic shock attributed to Candida infection: importance of empiric therapy and source control. Clin Infect Dis 2012; 54: 1739-1746.
16. Nucci M, Anaissie E, Betts RF et al. Early removal of central venous catheter in patients with candidemia does not improve outcome: analysis of 842 patients from 2 randomized clinical trials. Clin Infect Dis 2010; 51: 295-303.
17. Grim SA, Berger K, Teng C et al. Timing of susceptibility-based antifungal drug administration in patients with Candida bloodstream infection: correlation with outcomes. J Antimicrob Chemother 2012; 67: 707-714.
18. Andes DR, Safdar N, Baddley JW et al. Impact of treatment strategy on outcomes in patients with candidemia and other forms of invasive candidiasis: a patient-level quantitative review of randomized trials. Clin Infect Dis 2012; 54: 1110-1122.
19. Garnacho-Montero J, Diaz-Martin A, Garcia-Cabrera E, Ruiz Perez de Pipaon M, Hernandez-Caballero C, Lepe-Jimenez JA. Impact on hospital mortality of catheter removal and adequate antifungal therapy in Candida spp. bloodstream infections. J Antimicrob Chemother 2013; 68: 206-213.
20. Rodriguez D, Park BJ, Almirante B et al. Impact of early central venous catheter removal on outcome in patients with candidaemia. Clin Microbiol Infect 2007; 13: 788-793.
21. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40: 373-383.
22. Bone RC, Balk RA, Cerra FB et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992; 101: 1644-1655.
23. Mermel LA, Allon M, Bouza E et al. Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis 2009; 49: 1-45.
24. Luo G, Mitchell TG. Rapid identification of pathogenic fungi directly from cultures by using multiplex PCR. J Clin Microbiol 2002; 40: 2860-2865.
25. White TJ, Bruns TD, Lee SB, Taylor JW. Amplification and direct sequencing of fungal ribosomal RNA genes for phylogenetics. In: Innis MA, Gelfand DH, Sninsky JJ, Whit TJ, eds, PCR protocols: a guide to methods and applications. San Diego, CA: Academic Press, Inc., 1990; 315-322.
26. Rodriguez-Tudela JL, Arendrup MC, Barchiesi F et al. EUCAST definitive document EDef 7.1: method for the determination of broth dilution MICs of antifungal agents for fermentative yeasts. Clin Microbiol Infect 2008; 14: 398-405.
27. Arendrup MC, Cuenca-Estrella M, Lass-Florl C, Hope W. EUCAST technical note on the EUCAST definitive document EDef 7.2: method for the determination of broth dilution minimum inhibitory concentrations of antifungal agents for yeasts EDef 7.2 (EUCAST-AFST). Clin Microbiol Infect 2012; 18: E246-E247.
28. Rodriguez D, Almirante B, Park BJ et al. Candidemia in neonatal intensive care units: Barcelona, Spain. Pediatr Infect Dis J 2006; 25: 224-229.
29. Peman J, Canton E, Linares-Sicilia MJ et al. Epidemiology and antifungal susceptibility of bloodstream fungal isolates in pediatric patients: a Spanish multicenter prospective survey. J Clin Microbiol 2011; 49: 4158-4163.
30. Almirante B, Rodriguez D, Cuenca-Estrella M et al. Epidemiology, risk factors, and prognosis of Candida parapsilosis bloodstream infections: case-control population-based surveillance study of patients in Barcelona, Spain, from 2002 to 2003. J Clin Microbiol 2006; 44: 1681-1685.
31. * guideline for the diagnosis and management of Candida diseases 2012: Prevention and management of invasive infections in neonates and children caused by Candida spp. Clin Microbiol Infect 2012; 18(Suppl 7): 38-52.
32. Pappas PG, Kauffman CA, Andes D et al. Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis 2009; 48: 503-535.
33. Peman J, Canton E, Orero A, Viudes A, Frasquet J, Gobernado M. Epidemiology of candidemia in Spain-multicenter study. Rev Iberoam Micol 2002; 19: 30-35.
34. Lin MY, Carmeli Y, Zumsteg J et al. Prior antimicrobial therapy and risk for hospital-acquired Candida glabrata and Candida krusei fungemia: a case-case-control study. Antimicrob Agents Chemother 2005; 49: 4555-4560.
35. Malani A, Hmoud J, Chiu L, Carver PL, Bielaczyc A, Kauffman CA. Candida glabrata fungemia: experience in a tertiary care center. Clin Infect Dis 2005; 41: 975-981.
36. Cuenca-Estrella M, Rodriguez D, Almirante B et al. In vitro susceptibilities of bloodstream isolates of Candida species to six antifungal agents: results from a population-based active surveillance programme, Barcelona, Spain, 2002-2003. J Antimicrob Chemother 2005; 55: 194-199.